Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Rimesh Pal and Sanjay Bhadada.
Rimesh Pal
Connection Strength
13.213
Sanjay Bhadada
  1. Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis. Ther Adv Endocrinol Metab. 2021; 12:2042018821996482.
    View in: PubMed
    Score: 0.930
  2. High Prevalence of Hypocalcemia in Non-severe COVID-19 Patients: A Retrospective Case-Control Study. Front Med (Lausanne). 2020; 7:590805.
    View in: PubMed
    Score: 0.923
  3. COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail. Infect Disord Drug Targets. 2021; 21(5):e270421186842.
    View in: PubMed
    Score: 0.922
  4. Impaired anti-SARS-CoV-2 antibody response in non-severe COVID-19 patients with diabetes mellitus: A preliminary report. Diabetes Metab Syndr. 2021 Jan-Feb; 15(1):193-196.
    View in: PubMed
    Score: 0.920
  5. Cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020 10; 8(10):809.
    View in: PubMed
    Score: 0.906
  6. Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey. Diabetes Res Clin Pract. 2020 Aug; 166:108344.
    View in: PubMed
    Score: 0.894
  7. Awareness regarding COVID-19 and problems being faced by young adults with type 1 diabetes mellitus amid nationwide lockdown in India: A qualitative interview study. Prim Care Diabetes. 2021 02; 15(1):10-15.
    View in: PubMed
    Score: 0.892
  8. Managing common endocrine disorders amid COVID-19 pandemic. Diabetes Metab Syndr. 2020 Sep - Oct; 14(5):767-771.
    View in: PubMed
    Score: 0.885
  9. Cash, currency and COVID-19. Postgrad Med J. 2020 07; 96(1137):427-428.
    View in: PubMed
    Score: 0.882
  10. Reply to comment on "Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?" Diabetes Res Clin Pract. 2020 06; 164:108192.
    View in: PubMed
    Score: 0.881
  11. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020 Jul - Aug; 14(4):513-517.
    View in: PubMed
    Score: 0.881
  12. Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Res Clin Pract. 2020 05; 163:108146.
    View in: PubMed
    Score: 0.876
  13. COVID-19 and non-communicable diseases. Postgrad Med J. 2020 07; 96(1137):429-430.
    View in: PubMed
    Score: 0.874
  14. COVID-19-associated mucormycosis: An updated systematic review of literature. Mycoses. 2021 Dec; 64(12):1452-1459.
    View in: PubMed
    Score: 0.238
  15. Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. 2021 Jun 08.
    View in: PubMed
    Score: 0.237
  16. Resurgence of COVID-19 and diabetes in India. Diabetes Metab Syndr. 2021 May-Jun; 15(3):1037-1038.
    View in: PubMed
    Score: 0.236
  17. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes Metab Syndr. 2021 Mar-Apr; 15(2):505-508.
    View in: PubMed
    Score: 0.233
  18. Spontaneous simultaneous bilateral quadriceps tendon rupture associated with severe vitamin D deficiency. Clin Endocrinol (Oxf). 2019 10; 91(4):580-582.
    View in: PubMed
    Score: 0.209
  19. Islands of bone within bone. Postgrad Med J. 2019 May; 95(1123):289.
    View in: PubMed
    Score: 0.205
  20. BROWN TUMOR OF THE PALATE. Endocr Pract. 2018 Jun; 24(6):605.
    View in: PubMed
    Score: 0.189
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.